Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000802269 | SCV000942093 | uncertain significance | Fetal akinesia deformation sequence 1; Congenital myasthenic syndrome 11 | 2022-08-16 | criteria provided, single submitter | clinical testing | This sequence change replaces glycine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 223 of the RAPSN protein (p.Gly223Ser). This variant is present in population databases (rs138863694, gnomAD 0.009%). This variant has not been reported in the literature in individuals affected with RAPSN-related conditions. ClinVar contains an entry for this variant (Variation ID: 647705). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Revvity Omics, |
RCV003133632 | SCV003813740 | uncertain significance | not provided | 2022-11-28 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001830731 | SCV002089146 | uncertain significance | Congenital myasthenic syndrome | 2020-02-26 | no assertion criteria provided | clinical testing |